Nutrition Capital Network


Nutrition Capital Network news: BASF acquires omega 3 technology firm Equateq

Nutrition Capital Network facilitates financing and asset sales for growing companies and introduces investors to the next generation of successful brands & technology in the nutrition and health & wellness industries. Below is news from June.

BASF (Ludwigshafen, Germany) has acquired Equateq Ltd., a manufacturer of concentrated omega-3 fatty acids using proprietary chromatographic separation methods. Equateq, which has a production site located on the Isle of Lewis in Scotland with 47 employees, will be integrated into the Pharma Ingredients & Services unit, which is part of BASF’s Nutrition & Health division.

Financial details were not disclosed. “Equateq’s technologies will enable us to customize fatty acid concentrates with variable ratios of EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) at concentration levels of up to 99 percent purity. This is unique in the market,” said Martin Widmann, senior vice president of  BASF’s Pharma Ingredients & Services. BASF is an NCN Cornerstone Investor.

Disclaimer: NCN does not warrant the accuracy, reliability, or timeliness of any NCN news item. Before relying on any NCN News item the information should be independently verified.

For more finance and investment information, visit Nutrition Capital Network news.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.